3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
CNS
1
Conditions
Multiple Myeloma
90
Neoplasms, Plasma Cell
28
Central Nervous System Neoplasms
11
Recurrence
10
Glioblastoma
10
Neoplasms
9
Carcinoma, Hepatocellular
9
Brain Neoplasms
9
Gliosarcoma
8
Melanoma
6
Lung Neoplasms
6
Leukemia
6
Glioma
6
Carcinoma, Non-Small-Cell Lung
6
Waldenstrom Macroglobulinemia
5
Prostatic Neoplasms
5
Lymphoma, Mantle-Cell
5
Myeloproliferative Disorders
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Immunoglobulin Light-chain Amyloidosis
4
Colorectal Neoplasms
4
Carcinoma, Renal Cell
4
Astrocytoma
4
Uveal Melanoma
3
Oligodendroglioma
3
Neuroblastoma
3
Myelodysplastic-Myeloproliferative Diseases
3
Myelodysplastic Syndromes
3
Medulloblastoma
3
Interventions
Filgrastim
10
Cyclophosphamide
8
Granulocyte Colony-Stimulating Factor
6
Melphalan
5
Busulfan
5
Vincristine
4
Topotecan
4
Temozolomide
4
Stem Cell Transplantation
4
Peripheral Blood Stem Cell Transplantation
4
Ifosfamide
4
Etoposide
4
Thiotepa
3
Radiotherapy
3
Mesna
3
Itraconazole
3
Doxorubicin
3
Cisplatin
3
Carboplatin
3
sargramostim
2
fludarabine
2
Therapeutics
2
Sirolimus
2
Radiotherapy, Intensity-Modulated
2
Nivolumab
2
Drug Therapy
2
Bone Marrow Transplantation
2
Blood Specimen Collection
2
Amplified Fragment Length Polymorphism Analysis
2
trioctyl phosphine oxide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Wilms Tumor
×
Thalidomide
×
Clear all
NCT01661400
2024-01-31
ASCR
Washington University School of Medicine
Phase 1
Completed
14 enrolled